When Pradaxa hit the market in 2010 as a blood thinner that should prevent
strokes and unsafe coagulations of the blood, it was advertised as “safe
and effective.” Doctors wrote prescription after prescription of
the drug for thousands of patients around the country. Before 2011 was
out, however, more than 500 people died due to complications caused directly
by Pradaxa use.
The blood thinner Pradaxa could cause sudden and severe internal hemorrhaging
in users. Without immediate medical attention, the bleeding event could
prove fatal. A previous anticoagulant that was popular on the market –
Coumadin – was manufactured with an antidote that would stop bleeding
in case such a side effect occurred; Pradaxa was released to the public
without any such antidote.
In 2014, Pradaxa’s manufacturer, German pharmaceutical giant Boehringer
Ingelheim agreed to pay $650 million to settle a total of 4,000 lawsuits,
both state and federal, that had been filed due to the drug’s dangerous
side effects. The company did not accept any responsibility for the dangers
of the drug, insisting that it was safe all along. The massive settlement
also did not excuse Boehringer from any future lawsuits that may arise
from future users or future discoveries of complications.
If you or someone you know has been affected, injured, or lost their life
due to Pradaxa,
contact Williams DeClark Tuschman Co., L.P.A. We have been looking into Pradaxa
lawsuits and studying the groundwork and outcome of such cases. With our
help, you may be able to create an individual lawsuit or opt into a mass
419.318.0772 today for more information.